ArticleFrontiers in oncology2023

Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials.

Zhanpeng Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.